Jason Newland, M.D., M.Ed.  jgnewland@wustl.edu

Profile picture
Professor of Pediatrics, Infectious Diseases
Infectious Diseases

phone: (314) 454-6050


  • BS, University of Notre Dame1996
  • MD, University of Oklahoma College of Medicine2000
  • M Ed, University of Cincinnati, Cincinnati Children's Hospital Medical Center2011


  • Intern and Resident in Pediatrics, University of Nebraska Medical Center and Creighton Medical Center2000 - 2003
  • Fellow, Pediatric Infectious Diseases, Children's Hospital of Philadelphia2003 - 2006
  • Summer Program in Clinical Effectiveness, Harvard School of Public Health2010 - 2010
  • Advanced Improvement Methods, Cincinnati Children's Hospital2013 - 2013
  • Patient Safety Executive Development Program (IHI)2014 - 2014

Licensure and Board Certification

  • 2006 - PresMO, Physician and Surgeon
  • 2006 - PresKS, Physician and Surgeon
  • 2007 - PresABP Subspecialty, Pediatric Infectious Diseases
  • 2015 - PresAmerican Board of Pediatrics

Honors and Awards

  • Eagle Scout1990
  • Novartis Community Service Award, University of Oklahoma College of Medicine1998
  • Podilarian Award for commitment, leadership, and advocacy on the part of patients and fellow students1999
  • William A. Delaney Jr. Award, Outstanding Senior Student in Pediatrics, University of Oklahoma College of Medicine2000
  • IDSA Kass Award for outstanding research by a student or resident2002
  • Pediatric House Officer Teaching Award, University of Nebraska/Creighton University2002
  • George Measaki Award for Outstanding Resident Research, University of Nebraska/Creighton University2003
  • Stephen A. Chartrand Award for Community Service, University of Nebraska/Creighton University2003
  • Teaching Fellow of the Year, Children's Hospital of Philadelphia2004
  • Daniel Scagliotti Award, Educator of the Year, Children's Mercy Hospital-Kansas City2008
  • Kansas City Business Journal Best Doctors List2011
  • Golden Apple Mercy Mentor, Children's Mercy Hospital-Kansas City2012
  • John and Marion Kreamer Research Excellence Award, Excellence in Pediatric Research, Children's Mercy Hospital-Kansas City2013
  • Member, Society of Pediatric Research2013
  • Fellow of Pediatric Infectious Diseases Society2014
  • Kansas City Business Journal Best Doctors List2014
  • Patient Safety Executive Development Scholarship2014
  • Golden Apple Mercy Mentor, Children's Mercy Hospital2014 - 2015
  • Participant, White House Forum on Antibiotic Stewardship2015
  • Member, American Pediatric Society2016
  • Washington University Department of Pediatrics Outstanding Teacher Award-Subspeciality2017
  • CDC/ATSDR Charles C. Shepard Science Award, Assessment, 20172017
  • St. Louis Children's Hospital Residency Program Lecturer of the Month-January 20182018
  • Academic Medical Leadership Program For Physicians and Scientists2019
  • Washington University Department of Pediatrics Outstanding Teacher Award-Subspeciality2019
  • F. Sessions Cole, MD Award in Clinical Excellence 20192019
  • Best Doctor's in America St. Louis - 20192019 - 2020
  • Washington University School of Medicine Department of Pediatrics Outstanding Commitment to Community Physicians Award2020

Recent Publications view all (143)

  1. Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. J Pediatric Infect Dis Soc. 2021;10(1):34-48. PMCID:PMC7543452  PMID:32918548 
  2. Variability in Ceftriaxone Dosing Across 32 US Acute Care Children's Hospitals. J Pediatric Infect Dis Soc. 2021. PMID:33528009 
  3. Practical School Algorithms for Symptomatic or SARS-CoV-2-Exposed Students Are Essential for Returning Children to In-Person Learning. J Pediatr. 2021;229:275-277. PMCID:PMC7516575  PMID:32980377 
  4. Utilization of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative electronic mailing list (listserv) by healthcare professionals. Infect Control Hosp Epidemiol. 2020;1-3. PMID:33353577 
  5. Experiences from the Missouri Antimicrobial Stewardship Collaborative: A mixed methods study. Infect Control Hosp Epidemiol. 2020;41(12):1455-1457. PMID:32746951 
  6. Association of Intrapartum Risk Factors and Infant Clinical Indicators with Culture Confirmed Early Onset Neonatal Sepsis in a Secondary Care Rural Hospital in India. J Trop Pediatr. 2020. PMID:32853356 
  7. The current state of antifungal stewardship among pediatric antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2020;1-6. PMID:32662383 
  8. A qualitative study examining pediatric clinicians' perceptions of delayed vaccine schedules. Vaccine. 2020;38(30):4740-4746. PMCID:PMC7282958  PMID:32418792 
  9. Reductions in Parent Interest in Receiving Antibiotics Following a 90-Second Video Intervention in Outpatient Pediatric Clinics. J Pediatr. 2020. PMID:32553835 
  10. Children in the Eye of the Pandemic Storm-Lessons From New York City. JAMA Pediatr. 2020;e202438. PMID:32492094 
  11. Understanding antibiotic prophylaxis prescribing in pediatric surgical specialties. Infect Control Hosp Epidemiol. 2020;41(6):666-671. PMID:32252848 
  12. Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2. J Pediatric Infect Dis Soc. 2020. PMCID:PMC7188128  PMID:32318706 
  13. Effect of Combined Clinical Practice Guideline and Electronic Order Set Implementation on Febrile Infant Evaluation and Management. Pediatr Emerg Care. 2020. PMID:32221058 
  14. Inappropriate antibiotic surgical prophylaxis in pediatric patients: A national point-prevalence study. Infect Control Hosp Epidemiol. 2020;1-3. PMID:32127068 
  15. Appropriateness of Antibiotic Prescribing in U.S. Children's Hospitals: A National Point Prevalence Survey. Clin Infect Dis. 2020. PMID:31942952 
  16. Improving Antibiotic Use Through Quality Improvement Methods: Quality Improvement for Antibiotic Use. Jt Comm J Qual Patient Saf. 2019;45(12):787-788. PMID:31783950 
  17. Skin and Soft Tissue Infection Treatment and Prevention Practices by Pediatric Infectious Diseases Providers. J Pediatric Infect Dis Soc. 2019. PMID:31773168 
  18. Practices, Perceptions, and Attitudes in the Evaluation of Critically Ill Children for Bacteremia: A National Survey. Pediatr Crit Care Med. 2019. PMID:31702704 
  19. Application of an antibiotic spectrum index in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2019;40(10):1181-1183. PMID:31352907 
  20. Clinical impact of an antimicrobial stewardship program on high-risk pediatric patients. Infect Control Hosp Epidemiol. 2019;40(9):968-973. PMID:31311616 
  21. Use of Antimicrobial Agents in Hospitalized Children for Noninfectious Indications. J Pediatric Infect Dis Soc. 2019. PMID:32677678 
  22. World Health Organization Treatment Recommendations for Nonsevere Fast-Breathing Pneumonia Need to Be Updated. JAMA Pediatr. 2019;173(6):607-608. PMID:30985899 
  23. Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients. Infect Dis Ther. 2019;8(2):301-306. PMCID:PMC6522555  PMID:30989592 
  24. Determinants of Initial Antibiotic Duration in Very Low Birth Weight Neonates. Infect Dis Ther. 2019;8(2):209-217. doi:10.1007/s40121-019-0241-6  PMCID:PMC6522625  PMID:30825133 
  25. The Infectious Diseases Society of America's 10 × '20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × '20 a Possibility? Clin Infect Dis. 2019. PMID:30715222 
  26. Can a Septic Hip Decision Rule Aid in the Evaluation of Suspected Pediatric Musculoskeletal Infections? J Emerg Med. 2019. PMID:30679068 
  27. Development of an antimicrobial stewardship program in an integrated healthcare system. Am J Health Syst Pharm. 2019;76(1):34-43. PMID:31603982 
  28. Route of administration for antibiotics with high oral bioavailability. Infect Control Hosp Epidemiol. 2018;1-2. PMID:30587255 
  29. Variability of surgical prophylaxis in penicillin-allergic children. Infect Control Hosp Epidemiol. 2018;39(12):1480-1483. PMID:30526715 
  30. Getting Over Our Inpatient Oral Antibiotic Aversion. Pediatrics. 2018;142(6). PMID:30510032 
  31. Epidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009-2016. Infect Control Hosp Epidemiol. 2018;1-4. PMID:30370879 
  32. Measuring shared decision-making in the pediatric outpatient setting: Psychometric performance of the SDM-Q-9 and CollaboRATE among English and Spanish speaking parents in the US Midwest. Patient Educ Couns. 2018. PMID:30448047 
  33. From paper to practice: Strategies for improving antibiotic stewardship in the pediatric ambulatory setting. Curr Probl Pediatr Adolesc Health Care. 2018. PMID:30322711 
  34. Improving Guideline-Based Streptococcal Pharyngitis Testing: A Quality Improvement Initiative. Pediatrics. 2018;142(1). PMID:29925574 
  35. Development and implementation of a mobile device-based pediatric electronic decision support tool as part of a national practice standardization project. J Am Med Inform Assoc. 2018. PMID:29889255 
  36. Variability in Antibiotic Use Across PICUs. Pediatr Crit Care Med. 2018;19(6):519-527. PMID:29533352 
  37. Protocol for a randomised trial of higher versus lower intensity patient-provider communication interventions to reduce antibiotic misuse in two paediatric ambulatory clinics in the USA. BMJ Open. 2018;8(5):e020981. PMCID:PMC5942422  PMID:29743330 
  38. Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting. Clin Infect Dis. 2018. PMID:29590355 
  39. Zika Virus Infection in Children. Infect Dis Clin North Am. 2018;32(1):215-224. PMID:29406975 
  40. Old and New Infections of Childhood. Infect Dis Clin North Am. 2018;32(1):xiii-xiv. PMID:29406985 
  41. Infections in Children. Infect Dis Clin North Am. 2018;32(1):i. PMID:29406980 
  42. Antimicrobial Stewardship in Neonates: Challenges and Opportunities. Neonatal Netw. 2018;37(2):116-123. PMID:29615159 
  43. Understanding inpatient antimicrobial stewardship metrics. Am J Health Syst Pharm. 2018;75(4):230-238. PMID:29436469 
  44. Characteristics of Pediatric Antimicrobial Stewardship Programs: Current Status of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative. Antibiotics (Basel). 2018;7(1). PMID:29370071 
  45. Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next. J Pediatric Infect Dis Soc. 2017. PMID:29267871 
  46. Trends in Intravenous Antibiotic Duration for Urinary Tract Infections in Young Infants. Pediatrics. 2017;140(6). PMID:29097611 
  47. Cost and Potential Avoidability of Antibiotic-Associated Adverse Drug Reactions in Children. J Pediatric Infect Dis Soc. 2017. PMID:29165624 
  48. Accuracy of Administrative Data for Antimicrobial Administration in Hospitalized Children. J Pediatric Infect Dis Soc. 2017. PMID:28992185 
  49. Development and Application of an Antibiotic Spectrum Index for Benchmarking Antibiotic Selection Patterns Across Hospitals. Infect Control Hosp Epidemiol. 2017;38(8):993-997. PMID:28560946 
  50. White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs. J Infect Dis. 2017;216(2):228-236. PMID:28475768 
  51. Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection. Antimicrob Agents Chemother. 2017;61(5). PMID:28289030 
  52. Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS): A Quality Improvement Collaborative. J Pediatric Infect Dis Soc. 2017. PMID:28379408 
  53. Current State of Antimicrobial Stewardship in Children's Hospital Emergency Departments Infect Control Hosp Epidemiol. 2017;38(4):469-475. PMID:28173888 
  54. Experience With a Care Process Model in the Evaluation of Pediatric Musculoskeletal Infections in a Pediatric Emergency Department. Pediatr Emerg Care. 2017. PMID:28328692 
  55. Variability in Antifungal and Antiviral Use in Hospitalized Children. Infect Control Hosp Epidemiol. 2017;1-4. PMID:28294077 
  56. Extracorporeal Membrane Oxygenation-Associated Bloodstream Infections In Children. Pediatr Infect Dis J. 2017;36(3):346-347. PMID:27902647 
  57. Clinical Impact of an Antibiotic Stewardship Program at a Children's Hospital. Infect Dis Ther. 2017;6(1):103-113. PMCID:PMC5336414  PMID:27913975 
  58. Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application. Infect Dis Ther. 2017;6(1):57-67. PMCID:PMC5336419  PMID:28039666 
  59. Of the Phrensy: an update on the epidemiology and pathogenesis of bacterial meningitis in the pediatric population. F1000Res. 2017;6. PMCID:PMC5288681  PMID:28184287 
  60. Integrating a Rapid Diagnostic Test and Antimicrobial Stewardship: Optimizing Discharge Antibiotics in Skin and Soft Tissue Infections. Pediatr Infect Dis J. 2016. PMID:27649364 
  61. Best Practices for Treatment of Invasive Methicillin-Susceptible Staphylococcus aureus Infections: The Case for Oxacillin. J Pediatric Infect Dis Soc. 2016. PMID:27609072 
  62. Impact of an Educational Intervention to Improve Antibiotic Prescribing for Nurse Practitioners in a Pediatric Urgent Care Center J Pediatr Health Care. 2016. doi:10.1016/j.pedhc.2016.07.005  PMID:27567148 
  63. Failure to Thrive Hospitalizations and Risk Factors for Readmission to Children's Hospitals. Hosp Pediatr. 2016;6(8):468-75. PMID:27439432 
  64. Costs of Antimicrobial Stewardship Programs at US Children's Hospitals. Infect Control Hosp Epidemiol. 2016;37(7):852-4. PMID:27020133 
  65. Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients. Antimicrob Agents Chemother. 2016;60(7):4237-43. PMCID:PMC4914666  PMID:27139486 
  66. Extended- Versus Narrower-Spectrum Antibiotics for Appendicitis. Pediatrics. 2016;138(1). PMID:27354453 
  67. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative. Clin J Am Soc Nephrol. 2016. PMID:27340282 
  68. Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis. Kidney Int. 2016;89(6):1346-54. PMID:27165827 
  69. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77. PMID:27080992 
  70. Executive Summary: Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):1197-202. PMID:27118828 
  71. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016;315(17):1864-73. PMID:27139059 
  72. Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study. Infect Dis Ther. 2016. doi:10.1007/s40121-016-0105-2  PMID:26972929 
  73. Reductions in neonatal listeriosis: "Collateral benefit" of Group B streptococcal prophylaxis? J Infect. 2016;72(3):317-23. doi:10.1016/j.jinf.2015.12.015  PMID:26772166 
  74. Outpatient Parenteral Antimicrobial Therapy in Pediatric Medicaid Enrollees. J Pediatric Infect Dis Soc. 2016. doi:10.1093/jpids/piv106  PMID:26803327 
  75. Pediatric Antimicrobial Discharge Stewardship: An Unmet Need. JAMA Pediatr. 2016;1-2. doi:10.1001/jamapediatrics.2015.3369  PMID:26752682 
  76. Encouraging Antibiotic Development and Endorsing Conservation: Tandem Approaches to Our Declining Antibiotic Reserves. Infect Control Hosp Epidemiol. 2016;1-2. doi:10.1017/ice.2015.329  PMID:26732605 
  77. Antimicrobial Stewardship Barriers and Goals in Pediatric Oncology and Bone Marrow Transplantation: A Survey of Antimicrobial Stewardship Practitioners. Infect Control Hosp Epidemiol. 2015;1-5. doi:10.1017/ice.2015.295  PMID:26639441 
  78. Linezolid-Resistant Staphylococcus aureus in Children With Cystic Fibrosis. J Pediatric Infect Dis Soc. 2015;4(4):e163-5. doi:10.1093/jpids/piv071  PMID:26501474 
  79. Boiling Over: The Antimicrobial Stewardship Stew May Finally Be Ready. J Pediatric Infect Dis Soc. 2015;4(4):394-6. doi:10.1093/jpids/piv063  PMID:26501469 
  80. Identifying Antimicrobial Stewardship Targets for Pediatric Surgical Patients. J Pediatric Infect Dis Soc. 2015;4(4):e100-8. doi:10.1093/jpids/piv022  PMID:26407258 
  81. Clinical variables and Staphylococcus aureus virulence factors associated with venous thromboembolism in children. Thromb Res. 2015. doi:10.1016/j.thromres.2015.11.029  PMID:26709039 
  82. Management of the 2014 Enterovirus 68 Outbreak at a Pediatric Tertiary Care Center. Clin Ther. 2015;37(11):2411-8. doi:10.1016/j.clinthera.2015.06.015  PMID:26602757 
  83. Surgical Site Infection Reduction by the Solutions for Patient Safety Hospital Engagement Network. Pediatrics. 2015;136(5):e1353-60. doi:10.1542/peds.2015-0580  PMID:26438709 
  84. Cost of antimicrobial therapy across US children's hospitals. Infect Control Hosp Epidemiol. 2015;36(10):1242-4. doi:10.1017/ice.2015.159  PMID:26166408 
  85. Clinical Impact of an Antimicrobial Stewardship Program on Pediatric Hospitalist Practice, a 5-Year Retrospective Analysis. Hosp Pediatr. 2015;5(10):520-7. doi:10.1542/hpeds.2014-0250  PMID:26427920 
  86. New Horizons for Pediatric Antibiotic Stewardship. Infect Dis Clin North Am. 2015;29(3):503-11. doi:10.1016/j.idc.2015.05.003  PMCID:PMC4589217  PMID:26154663 
  87. Antibiotic utilization based on primary treatment of pediatric empyema. J Surg Res. 2015;196(2):320-4. doi:10.1016/j.jss.2015.02.053  PMID:25824668 
  88. Database Research for Pediatric Infectious Diseases. J Pediatric Infect Dis Soc. 2015;4(2):143-50. doi:10.1093/jpids/piv007  PMID:26407414 
  89. Clinical diagnoses and antimicrobials predictive of pediatric antimicrobial stewardship recommendations: a program evaluation. Infect Control Hosp Epidemiol. 2015;36(6):673-80. doi:10.1017/ice.2015.45  PMCID:PMC4583769  PMID:25773192 
  90. Review of Twitter for infectious diseases clinicians: useful or a waste of time? Clin Infect Dis. 2015;60(10):1533-40. doi:10.1093/cid/civ071  PMID:25652087 
  91. Enterovirus d68. A focused review and clinical highlights from the 2014 U.S. Outbreak. Ann Am Thorac Soc. 2015;12(5):775-81. doi:10.1513/AnnalsATS.201412-592FR  PMID:25714788 
  92. Infection prevention and control practices in children's hospitals. Infect Control Hosp Epidemiol. 2015;36(5):597-600. doi:10.1017/ice.2015.23  PMID:25666492 
  93. An Enterovirus D68 Outbreak Highlights the Value of Pediatric Infectious Disease Specialists. J Pediatric Infect Dis Soc. 2015;4(1):87-8. doi:10.1093/jpids/piu117  PMID:26407368 
  94. Antimicrobial stewardship programs in freestanding children's hospitals. Pediatrics. 2015;135(1):33-9. doi:10.1542/peds.2014-2579  PMID:25489018 
  95. Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. J Infect Dis. 2014;210(8):1270-4. doi:10.1093/infdis/jiu245  PMCID:PMC4271072  PMID:24795475 
  96. Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative. Pediatr Nephrol. 2014;29(9):1477-84. doi:10.1007/s00467-014-2891-7  PMID:25055994 
  97. Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States. Infect Control Hosp Epidemiol. 2014;35(3):265-71. doi:10.1086/675277  PMID:24521592 
  98. Impact of Infectious Diseases Society of America/Pediatric Infectious Diseases Society guidelines on treatment of community-acquired pneumonia in hospitalized children. Clin Infect Dis. 2014;58(6):834-8. doi:10.1093/cid/ciu013  PMID:24399088 
  99. Linezolid use in hospitalized children. Pediatr Infect Dis J. 2014;33(1):e14-8. doi:10.1097/INF.0000000000000011  PMID:24352192 
  100. Antibiotic Management of Animal Bites in Children During the Methicillin-Resistant Staphylococcus aureus Era. J Pediatric Infect Dis Soc. 2013;2(4):379-81. doi:10.1093/jpids/pis096  PMID:26619500 
  101. Diagnosis and acute management of patients with concussion at children's hospitals. Arch Dis Child. 2013;98(12):934-8. doi:10.1136/archdischild-2012-303588  PMID:23852997 
  102. Identifying targets for antimicrobial stewardship in children's hospitals. Infect Control Hosp Epidemiol. 2013;34(12):1252-8. doi:10.1086/673982  PMID:24225609 
  103. Pediatric antimicrobial susceptibility trends across the United States. Infect Control Hosp Epidemiol. 2013;34(12):1244-51. doi:10.1086/673974  PMID:24225608 
  104. Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda. Pediatr Infect Dis J. 2013;32(12):e456-65. doi:10.1097/INF.0b013e31829f0460  PMID:23958812 
  105. Incidence, classification, and risk stratification for Candida central line-associated bloodstream infections in pediatric patients at a tertiary care children's hospital, 2000-2010. Infect Control Hosp Epidemiol. 2013;34(12):1266-71. doi:10.1086/673988  PMID:24225611 
  106. Antimicrobial stewardship in pediatrics: how every pediatrician can be a steward. JAMA Pediatr. 2013;167(9):859-66. doi:10.1001/jamapediatrics.2013.2241  PMID:23857121 
  107. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J. 2013;32(6):e242-53. doi:10.1097/INF.0b013e318286c612  PMID:23838740 
  108. Microbiology and antimicrobial treatment of pediatric cervical lymphadenitis requiring surgical intervention. Int J Pediatr Otorhinolaryngol. 2013;77(5):817-20. doi:10.1016/j.ijporl.2013.02.018  PMID:23531371 
  109. Use of Administrative Data for the Identificationof Laboratory-Confirmed Influenza Infection: The Validity ofInfluenza-Specific ICD-9 Codes. J Pediatric Infect Dis Soc. 2013;2(1):63-6. doi:10.1093/jpids/pis052  PMID:26619444 
  110. The use of intravenous colistin among children in the United States: results from a multicenter, case series. Pediatr Infect Dis J. 2013;32(1):17-22. doi:10.1097/INF.0b013e3182703790  PMCID:PMC4427054  PMID:22935871 
  111. Variation in Antibiotic Use for Children Hospitalized With Inflammatory Bowel Disease Exacerbation: A Multicenter Validation Study. J Pediatric Infect Dis Soc. 2012;1(4):306-13. doi:10.1093/jpids/pis053  PMCID:PMC3656543  PMID:23687581 
  112. Influence of hospital guidelines on management of children hospitalized with pneumonia. Pediatrics. 2012;130(5):e823-30. doi:10.1542/peds.2012-1285  PMID:23090342 
  113. Impact of a Prospective-Audit-With-Feedback Antimicrobial Stewardship Program at a Children's Hospital. J Pediatric Infect Dis Soc. 2012;1(3):179-86. doi:10.1093/jpids/pis054  PMID:26619405 
  114. Clinicians' Attitudes Towards an Antimicrobial Stewardship Program at a Children's Hospital. J Pediatric Infect Dis Soc. 2012;1(3):190-7. doi:10.1093/jpids/pis045  PMID:26619407 
  115. Antimicrobial stewardship in pediatric care: strategies and future directions. Pharmacotherapy. 2012;32(8):735-43. doi:10.1002/j.1875-9114.2012.01155.x  PMID:23307521 
  116. Unmet medical need in infectious diseases. Clin Infect Dis. 2012;54(11):1677-8. doi:10.1093/cid/cis275  PMCID:PMC3404719  PMID:22474176 
  117. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int. 2012;32 Suppl 2:S32-86. doi:10.3747/pdi.2011.00091  PMCID:PMC3524923  PMID:22851742 
  118. Impact of a guideline on management of children hospitalized with community-acquired pneumonia. Pediatrics. 2012;129(3):e597-604. doi:10.1542/peds.2011-1533  PMID:22351891 
  119. The role of intention-to-treat analyses in randomized trials. Infect Control Hosp Epidemiol. 2012;33(2):207-8; author reply 208-10. doi:10.1086/663963  PMID:22227995 
  120. Demographics and microbiology of otorrhea through patent tubes failing ototopical and/or oral antibiotic therapy. Otolaryngol Head Neck Surg. 2011;145(6):1025-9. doi:10.1177/0194599811419098  PMID:21846926 
  121. Staphylococcal infections in the era of MRSA. Pediatr Rev. 2011;32(12):522-32. doi:10.1542/pir.32-12-522  PMID:22135422 
  122. Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic. Pediatr Infect Dis J. 2011;30(10):895-7. doi:10.1097/INF.0b013e3182214e28  PMID:21587093 
  123. Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J. 2011;30(9):736-9. doi:10.1097/INF.0b013e3182191c58  PMID:21772230 
  124. Influenza coinfection and outcomes in children with complicated pneumonia. Arch Pediatr Adolesc Med. 2011;165(6):506-12. doi:10.1001/archpediatrics.2010.295  PMID:21300649 
  125. Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood. J Hosp Med. 2011;6(5):256-63. doi:10.1002/jhm.872  PMCID:PMC3112472  PMID:21374798 
  126. Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool. Pediatr Infect Dis J. 2011;30(3):e38-40. doi:10.1097/INF.0b013e3182027c22  PMID:21079527 
  127. Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant. Paediatr Drugs. 2011;13(1):19-31. doi:10.2165/11536950-000000000-00000  PMID:21162598 
  128. Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia. PLoS One. 2011;6(5):e20325. doi:10.1371/journal.pone.0020325  PMCID:PMC3105054  PMID:21655259 
  129. Variability in antibiotic use at children's hospitals. Pediatrics. 2010;126(6):1067-73. doi:10.1542/peds.2010-1275  PMCID:PMC4677056  PMID:21078728 
  130. Antibiotics provide no additional short-term benefit to surgical management of paediatric skin abscesses. Evid Based Med. 2010;15(5):138-9. doi:10.1136/ebm1101  PMID:20643760 
  131. Purpose and design of antimicrobial stewardship programs in pediatrics. Pediatr Infect Dis J. 2010;29(9):862-3. doi:10.1097/INF.0b013e3181ef2507  PMID:20720473 
  132. A complete course of intravenous antibiotics vs a combination of intravenous and oral antibiotics for perforated appendicitis in children: a prospective, randomized trial. J Pediatr Surg. 2010;45(6):1198-202. doi:10.1016/j.jpedsurg.2010.02.090  PMID:20620320 
  133. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics. 2010;125(6):e1294-300. doi:10.1542/peds.2009-2867  PMID:20478934 
  134. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol. 2009;30(12):1211-7. doi:10.1086/648088  PMID:19852666 
  135. Update on terbinafine with a focus on dermatophytoses. Clin Cosmet Investig Dermatol. 2009;2:49-63. PMCID:PMC3047923  PMID:21436968 
  136. Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics. Paediatr Drugs. 2008;10(6):367-78. PMID:18998747 
  137. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr. 2007;150(3):306-10. doi:10.1016/j.jpeds.2006.11.054  PMID:17307552 
  138. Diagnosis of viral encephalitides: zoonotic-associated viruses. Pediatr Infect Dis J. 2006;25(8):741-2. doi:10.1097/01.inf.0000227815.41511.3b  PMID:16874176 
  139. Diagnosis of viral encephalitides: nonzoonotic-associated viruses. Pediatr Infect Dis J. 2006;25(8):739-40. doi:10.1097/01.inf.0000227818.40808.92  PMID:16874175 
  140. The child with aseptic meningitis. Pediatr Case Rev. 2003;3(4):218-21. doi:10.1097/01.PCA.0000083250.03358.9F  PMID:14520085 
  141. Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis. 2003;14(2):72-82. doi:10.1053/spid.2003.127223  PMID:12881794 
  142. Encephalitis associated with influenza B virus infection in 2 children and a review of the literature. Clin Infect Dis. 2003;36(7):e87-95. doi:10.1086/368184  PMID:12652406 
  143. Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol. 2000;120(1):209-17. PMCID:PMC1905619  PMID:10759785 
Last updated: 02/19/2021
© 2021 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130